{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:10:54Z","timestamp":1766182254910},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,12]]},"DOI":"10.7759\/cureus.54070","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T15:20:55Z","timestamp":1707751255000},"source":"Crossref","is-referenced-by-count":1,"title":["Understanding Ocular Surface Disease in Glaucoma: A Comparative Analysis of Symptoms and Objective Parameters"],"prefix":"10.7759","author":[{"given":"Jo\u00e3o","family":"Romano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9lia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gon\u00e7alo","family":"Godinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Paulo","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3181752c83","article-title":"Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire","volume":"18","author":"Goldberg I","year":"2009","unstructured":"Goldberg I, Clement CI, Chiang TH, Walt JG, Lee LJ, Graham S, Healey PR. Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire. J Glaucoma. 2009, 18:6-12. 10.1097\/IJG.0b013e3181752c83","journal-title":"J Glaucoma"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","unstructured":"The definition and classification of dry eye disease. report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007, 5:75-92. 10.1016\/s1542-0124(12)70081-2","journal-title":"Ocul Surf"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27492008000100004","article-title":"Tear film and ocular surface alterations in chronic users of antiglaucoma medications","volume":"71","author":"Baffa Ldo P","year":"2008","unstructured":"Baffa Ldo P, Ricardo JR, Dias AC, et al.. Tear film and ocular surface alterations in chronic users of antiglaucoma medications. Arq Bras Oftalmol. 2008, 71:18-21. 10.1590\/s0004-27492008000100004","journal-title":"Arq Bras Oftalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181ae8402","article-title":"The ocular surface in glaucoma","volume":"28","author":"Baudouin C","year":"2009","unstructured":"Baudouin C. The ocular surface in glaucoma. Cornea. 2009, 28:14-9. 10.1097\/ICO.0b013e3181ae8402","journal-title":"Cornea"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.06.023","article-title":"Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term","volume":"111","author":"Baudouin C","year":"2004","unstructured":"Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, Brignole F. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology. 2004, 111:2186-92. 10.1016\/j.ophtha.2004.06.023","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2012.10.002","article-title":"Conjunctival modifications induced by medical and surgical therapies in patients with glaucoma","volume":"13","author":"Mastropasqua L","year":"2013","unstructured":"Mastropasqua L, Agnifili L, Mastropasqua R, Fasanella V. Conjunctival modifications induced by medical and surgical therapies in patients with glaucoma. Curr Opin Pharmacol. 2013, 13:56-64. 10.1016\/j.coph.2012.10.002","journal-title":"Curr Opin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman RM","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000, 118:615-21. 10.1001\/archopht.118.5.615","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.03.045","article-title":"Evaluation of ocular surface disease in patients with glaucoma","volume":"120","author":"Mathews PM","year":"2013","unstructured":"Mathews PM, Ramulu PY, Friedman DS, Utine CA, Akpek EK. Evaluation of ocular surface disease in patients with glaucoma. Ophthalmology. 2013, 120:2241-8. 10.1016\/j.ophtha.2013.03.045","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001007","article-title":"Evaluation of ocular surface disease in patients with glaucoma: clinical parameters, self-report assessment, and keratograph analysis","volume":"27","author":"Portela RC","year":"2018","unstructured":"Portela RC, Fares NT, Machado LF, et al.. Evaluation of ocular surface disease in patients with glaucoma: clinical parameters, self-report assessment, and keratograph analysis. J Glaucoma. 2018, 27:794-801. 10.1097\/IJG.0000000000001007","journal-title":"J Glaucoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S229815","article-title":"Impact of ocular surface disease treatment in patients with glaucoma","volume":"14","author":"Mylla Boso AL","year":"2020","unstructured":"Mylla Boso AL, Gasperi E, Fernandes L, Costa VP, Alves M. Impact of ocular surface disease treatment in patients with glaucoma. Clin Ophthalmol. 2020, 14:103-11. 10.2147\/OPTH.S229815","journal-title":"Clin Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27492012000100005","article-title":"[Translation and validation of ocular surface disease index to Portuguese]","volume":"75","author":"Prigol AM","year":"2012","unstructured":"Prigol AM, Ten\u00f3rio MB, Matschinske R, Gehlen ML, Skare T. [Translation and validation of ocular surface disease index to Portuguese]. Arq Bras Oftalmol. 2012, 75:24-8. 10.1590\/s0004-27492012000100005","journal-title":"Arq Bras Oftalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung EW","year":"2008","unstructured":"Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008, 17:350-5. 10.1097\/IJG.0b013e31815c5f4f","journal-title":"J Glaucoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/460483","article-title":"The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study","volume":"2014","author":"Aydin Kurna S","year":"2014","unstructured":"Aydin Kurna S, Acikgoz S, Altun A, Ozbay N, Sengor T, Olcaysu OO. The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study. J Ophthalmol. 2014, 2014:460483. 10.1155\/2014\/460483","journal-title":"J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0534-z","article-title":"Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study","volume":"17","author":"Rolle T","year":"2017","unstructured":"Rolle T, Spinetta R, Nuzzi R. Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study. BMC Ophthalmol. 2017, 17:136. 10.1186\/s12886-017-0534-z","journal-title":"BMC Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2010.0133","article-title":"Symptoms and signs of tear film dysfunction in glaucomatous patients","volume":"27","author":"Valente C","year":"2011","unstructured":"Valente C, Iester M, Corsi E, Rolando M. Symptoms and signs of tear film dysfunction in glaucomatous patients. J Ocul Pharmacol Ther. 2011, 27:281-5. 10.1089\/jop.2010.0133","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-021-01802-4","article-title":"Repeatability of non-invasive keratograph break-up time measurements obtained using Oculus Keratograph 5M","volume":"41","author":"Garc\u00eda-Marqu\u00e9s JV","year":"2021","unstructured":"Garc\u00eda-Marqu\u00e9s JV, Mart\u00ednez-Albert N, Talens-Estarelles C, Garc\u00eda-L\u00e1zaro S, Cervi\u00f1o A. Repeatability of non-invasive keratograph break-up time measurements obtained using Oculus Keratograph 5M. Int Ophthalmol. 2021, 41:2473-83. 10.1007\/s10792-021-01802-4","journal-title":"Int Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/225845-understanding-ocular-surface-disease-in-glaucoma-a-comparative-analysis-of-symptoms-and-objective-parameters","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T15:20:57Z","timestamp":1707751257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/225845-understanding-ocular-surface-disease-in-glaucoma-a-comparative-analysis-of-symptoms-and-objective-parameters"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.54070","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,12]]}}}